Clinical Trial Update: A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study evaluating dara-RVd and teclistamab-RVd regimens in adults with multiple myeloma and notes that the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)
• TECVAYLI (TECLISTAMAB-CQYV)
• Velcade (bortezomib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING